|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00570 TRAD CHI MED
Nominal 
() | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 8,385,473 | -9.862% | 18,121,861 | 14,304,242 | 19,052,802 | 14,806,168 |
| Cost of Sales | (4,324,219) | -4.857% | (8,847,369) | (7,105,790) | (7,223,639) | (5,680,093) |
| Gross Profit | 4,061,254 | -14.643% | 9,274,492 | 7,198,452 | 11,829,163 | 9,126,075 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (158,768) | 232.373% | (9,366) | (10,073) | (13,879) | (53,725) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (874) | -51.336% | (3,699) | (3,479) | (10,749) | (15,874) | |
| Profit / (Loss) before Taxation | 299,434 | -57.636% | 1,224,533 | 840,109 | 2,520,280 | 2,230,091 | |
| Taxation | (85,291) | -5.076% | 171,537 | (119,144) | (396,856) | (369,447) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,164) | -91.721% | (110,870) | 43,521 | (190,566) | (197,389) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 210,979 | -63.545% | 1,285,200 | 764,486 | 1,932,858 | 1,663,255 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 67,954 | -8.340% | 133,788 | 153,426 | 159,453 | 197,066 |
| Depreciation & Amortisation | 561,477 | -1.004% | 1,133,271 | 1,099,397 | 849,597 | 684,079 |
| Directors' Emoluments | -- | -- | 8,932 | 8,971 | 8,003 | 8,515 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 4.190 | -63.534% | 25.520 | 15.180 | 38.380 | 33.030 |
| DPS (cts) | 0.000 | -- | 0.000 | 4.550 | 11.520 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | 29.974% | 30.016% | -- |
| Cash flow per share ($) | -- | -- | 0.232 | 0.217 | 0.158 | 0.045 |
| NBV per share ($) | 4.244 | -- | 4.202 | 4.005 | 3.916 | 3.587 |
| Remarks: | Real time quote last updated: -- |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 210,979 |
| %Change | -63.545% |
| EPS / (LPS) | RMB 0.042 |
| NBV Per Share (¥) | RMB 4.244 |